69 related articles for article (PubMed ID: 12165866)
1. BRCA2 and Smad3 synergize in regulation of gene transcription.
Preobrazhenska O; Yakymovych M; Kanamoto T; Yakymovych I; Stoika R; Heldin CH; Souchelnytskyi S
Oncogene; 2002 Aug; 21(36):5660-4. PubMed ID: 12165866
[TBL] [Abstract][Full Text] [Related]
2. Tumor-derived C-terminal mutations of Smad4 with decreased DNA binding activity and enhanced intramolecular interaction.
Kuang C; Chen Y
Oncogene; 2004 Feb; 23(5):1021-9. PubMed ID: 14647410
[TBL] [Abstract][Full Text] [Related]
3. Roles for lysine residues of the MH2 domain of Smad3 in transforming growth factor-beta signaling.
Imoto S; Sugiyama K; Sekine Y; Matsuda T
FEBS Lett; 2005 May; 579(13):2853-62. PubMed ID: 15907489
[TBL] [Abstract][Full Text] [Related]
4. TGFbeta1/Smad3 counteracts BRCA1-dependent repair of DNA damage.
Dubrovska A; Kanamoto T; Lomnytska M; Heldin CH; Volodko N; Souchelnytskyi S
Oncogene; 2005 Mar; 24(14):2289-97. PubMed ID: 15735739
[TBL] [Abstract][Full Text] [Related]
5. Cited2 modulates TGF-beta-mediated upregulation of MMP9.
Chou YT; Wang H; Chen Y; Danielpour D; Yang YC
Oncogene; 2006 Sep; 25(40):5547-60. PubMed ID: 16619037
[TBL] [Abstract][Full Text] [Related]
6. Cyclic adenosine 3',5'-monophosphate-elevating agents inhibit transforming growth factor-beta-induced SMAD3/4-dependent transcription via a protein kinase A-dependent mechanism.
Schiller M; Verrecchia F; Mauviel A
Oncogene; 2003 Dec; 22(55):8881-90. PubMed ID: 14654784
[TBL] [Abstract][Full Text] [Related]
7. The tumor suppressor KLF11 mediates a novel mechanism in transforming growth factor beta-induced growth inhibition that is inactivated in pancreatic cancer.
Buck A; Buchholz M; Wagner M; Adler G; Gress T; Ellenrieder V
Mol Cancer Res; 2006 Nov; 4(11):861-72. PubMed ID: 17114344
[TBL] [Abstract][Full Text] [Related]
8. Proteomics-based identification of proteins interacting with Smad3: SREBP-2 forms a complex with Smad3 and inhibits its transcriptional activity.
Grimsby S; Jaensson H; Dubrovska A; Lomnytska M; Hellman U; Souchelnytskyi S
FEBS Lett; 2004 Nov; 577(1-2):93-100. PubMed ID: 15527767
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis C viral proteins interact with Smad3 and differentially regulate TGF-beta/Smad3-mediated transcriptional activation.
Cheng PL; Chang MH; Chao CH; Lee YH
Oncogene; 2004 Oct; 23(47):7821-38. PubMed ID: 15334054
[TBL] [Abstract][Full Text] [Related]
10. Notch4 intracellular domain binding to Smad3 and inhibition of the TGF-beta signaling.
Sun Y; Lowther W; Kato K; Bianco C; Kenney N; Strizzi L; Raafat D; Hirota M; Khan NI; Bargo S; Jones B; Salomon D; Callahan R
Oncogene; 2005 Aug; 24(34):5365-74. PubMed ID: 16007227
[TBL] [Abstract][Full Text] [Related]
11. Smad3 is involved in the intracellular signaling pathways that mediate the inhibitory effects of transforming growth factor-beta on StAR expression.
Brand C; Souchelnytskiy S; Chambaz EM; Feige JJ; Bailly S
Biochem Biophys Res Commun; 1998 Dec; 253(3):780-5. PubMed ID: 9918804
[TBL] [Abstract][Full Text] [Related]
12. TGF-beta-induced nuclear localization of Smad2 and Smad3 in Smad4 null cancer cell lines.
Fink SP; Mikkola D; Willson JK; Markowitz S
Oncogene; 2003 Mar; 22(9):1317-23. PubMed ID: 12618756
[TBL] [Abstract][Full Text] [Related]
13. Cross-talk between the TGFbeta and Wnt signaling pathways in murine embryonic maxillary mesenchymal cells.
Warner DR; Greene RM; Pisano MM
FEBS Lett; 2005 Jul; 579(17):3539-46. PubMed ID: 15955531
[TBL] [Abstract][Full Text] [Related]
14. Activation of Smad transcriptional activity by protein inhibitor of activated STAT3 (PIAS3).
Long J; Wang G; Matsuura I; He D; Liu F
Proc Natl Acad Sci U S A; 2004 Jan; 101(1):99-104. PubMed ID: 14691252
[TBL] [Abstract][Full Text] [Related]
15. Cross-talk between the Notch and TGF-beta signaling pathways mediated by interaction of the Notch intracellular domain with Smad3.
Blokzijl A; Dahlqvist C; Reissmann E; Falk A; Moliner A; Lendahl U; Ibáñez CF
J Cell Biol; 2003 Nov; 163(4):723-8. PubMed ID: 14638857
[TBL] [Abstract][Full Text] [Related]
16. Transcriptional regulation of Smad2 is required for enhancement of TGFbeta/Smad signaling by TGFbeta inducible early gene.
Johnsen SA; Subramaniam M; Katagiri T; Janknecht R; Spelsberg TC
J Cell Biochem; 2002; 87(2):233-41. PubMed ID: 12244575
[TBL] [Abstract][Full Text] [Related]
17. Distortion of autocrine transforming growth factor beta signal accelerates malignant potential by enhancing cell growth as well as PAI-1 and VEGF production in human hepatocellular carcinoma cells.
Sugano Y; Matsuzaki K; Tahashi Y; Furukawa F; Mori S; Yamagata H; Yoshida K; Matsushita M; Nishizawa M; Fujisawa J; Inoue K
Oncogene; 2003 Apr; 22(15):2309-21. PubMed ID: 12700666
[TBL] [Abstract][Full Text] [Related]
18. Functional cooperation between Smad proteins and activator protein-1 regulates transforming growth factor-beta-mediated induction of endothelin-1 expression.
Rodríguez-Pascual F; Redondo-Horcajo M; Lamas S
Circ Res; 2003 Jun; 92(12):1288-95. PubMed ID: 12764024
[TBL] [Abstract][Full Text] [Related]
19. Selective inhibition of TGF-beta responsive genes by Smad-interacting peptide aptamers from FoxH1, Lef1 and CBP.
Cui Q; Lim SK; Zhao B; Hoffmann FM
Oncogene; 2005 Jun; 24(24):3864-74. PubMed ID: 15750622
[TBL] [Abstract][Full Text] [Related]
20. Expression and regulation of intracellular SMAD signaling in scleroderma skin fibroblasts.
Mori Y; Chen SJ; Varga J
Arthritis Rheum; 2003 Jul; 48(7):1964-78. PubMed ID: 12847691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
